Obesity

Weight Management Weight Loss Treatment Options Treatment Weight Loss Treatments Health Risks Causes Medications Diabetes Childhood Obesity

Wearable Data Show People Move Less After Starting GLP‑1 Weight‑Loss Drugs

ENDO 2026 presentations link the activity drop to greater risk of lean muscle loss and call for prescribing structured exercise with GLP‑1 therapy.

Stories older than 24h

Shaquille O’Neal Says Zepbound Has Eased His Obstructive Sleep Apnea

Penn Study Finds About 30% Lower Breast Cancer Rates Associated With GLP‑1 Use

Reappraisal Questions Health Harm of Ultraprocessed Foods

Employers and Insurers Pull Back Coverage for GLP‑1 Weight‑Loss Drugs

Zealand Pharma Shares Tumble After Survodutide Phase III Shows High Dropouts

Large Observational Studies Link GLP‑1 Drugs to Lower Cancer Rates and Slower Progression

Alcohol Triggers Hormone That Drives Savoury Cravings

AHA Says Exercise Should Be Prescribed as Core Part of Obesity Care

New Adiposity Rules Would Label Most Americans as Obese

Study Links Obesity to Molecular Changes That May Drive Early Breast Tumors to Invade

GLP‑1 Drugs Reshape Obesity Care as Surgery Delivers Larger, More Durable Weight Loss

Semaglutide Causes Weight Loss by Raising cAMP in Hindbrain Neurons, NIH Study Finds

Generic Semaglutide Hits Canadian Pharmacy Shelves

Heart Attack Grill Shuts Its Downtown Las Vegas Location After 15 Years

New Data Link GLP-1 Weight-Loss Drugs to Fewer Sick Days and Lower Disease Risks

8,500 Daily Steps Tied to Better Weight-Loss Maintenance in Pooled Analysis

Weight-Loss Jabs Linked to Halved Sick Days and Fewer NHS Visits, Real-World Study Finds

Fast, Supervised Diet Plan Outperforms Gradual Approach in Yearlong Obesity Trial

GLP-1 Drugs Linked to Lower Migraine Drug Use in Women, Fewer Asthma Flares in Danish Data